Furthermore, Maelstrom (MAEL) increases phosphorylated Akt1 expression in tumor cells, which phosphorylates the NF-κB subunit RelA, resulting in MDSC chemotaxis through the upregulation of CXCL8, thereby accelerating tumor progression within the TME (69, 70). The gene discussed is NFKB1; the disease is neoplasm.